10-K Decoder · All companies

Orchestra BioMed Holdings, Inc.

OBIO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$33.5M$2.64M+1,168%
Operating income−$51.8M−$64.3M+19.4%
Net income−$52.7M−$61.0M+13.6%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026

$Q3 2026Year earlierChange
Revenue$100K$900K−88.9%
Operating income−$23.3M−$20.3M−14.8%
Net income−$18.8M−$20.8M+9.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Orchestra BioMed's revenue in FY2025?
$33.5M in FY2025 (Fiscal year ended Dec 31, 2025), +1,168% vs $2.64M a year earlier, per its 10-K filed Mar 2026.
Was Orchestra BioMed profitable in FY2025?
No: net income was −$52.7M and operating income −$51.8M in FY2025.
What was Orchestra BioMed's revenue in Q3 2026?
$100K (−88.9% vs a year earlier), per its Form 10-Q filed Nov 10, 2026.